225 related articles for article (PubMed ID: 31202904)
1. Gene promoter methylation and cancer: An umbrella review.
Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M
Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904
[TBL] [Abstract][Full Text] [Related]
2. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
Chen B; Ying X; Bao L
Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
[TBL] [Abstract][Full Text] [Related]
3. [A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer].
Fang N; Gu J; Wei H; You J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):601-5. PubMed ID: 25130966
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
Guo Y; Long J; Lei S
J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527
[TBL] [Abstract][Full Text] [Related]
5. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
[TBL] [Abstract][Full Text] [Related]
6. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z
Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
[TBL] [Abstract][Full Text] [Related]
7. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
[TBL] [Abstract][Full Text] [Related]
8. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
Huang J; Luo JY; Tan HZ
PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
[TBL] [Abstract][Full Text] [Related]
9. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.
Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G
Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma.
Chen L; Wang Y; Liu F; Xu L; Peng F; Zhao N; Fu B; Zhu Z; Shi Y; Liu J; Wu R; Wang C; Yao S; Li Y
Sci Rep; 2018 Jan; 8(1):1439. PubMed ID: 29362385
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.
Zhao H; Wang S; Song C; Zha Y; Li L
World J Surg Oncol; 2016 Oct; 14(1):261. PubMed ID: 27733166
[TBL] [Abstract][Full Text] [Related]
12. Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis.
Chen R; Zheng Y; Zhuo L; Wang S
Sci Rep; 2017 Oct; 7(1):12783. PubMed ID: 28986566
[TBL] [Abstract][Full Text] [Related]
13. Association Between MGMT Promoter Methylation and Breast Cancer: a Meta-Analysis.
An N; Shi Y; Ye P; Pan Z; Long X
Cell Physiol Biochem; 2017; 42(6):2430-2440. PubMed ID: 28848211
[TBL] [Abstract][Full Text] [Related]
14. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
15. Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis.
Qiao B; Zhang Z; Li Y
Mol Genet Genomic Med; 2018 Jan; 6(1):69-76. PubMed ID: 29195029
[TBL] [Abstract][Full Text] [Related]
16. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
17. Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis.
Chen C; Hua H; Han C; Cheng Y; Cheng Y; Wang Z; Bao J
Int J Clin Exp Pathol; 2015; 8(9):11560-4. PubMed ID: 26617891
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.
Binabaj MM; Bahrami A; ShahidSales S; Joodi M; Joudi Mashhad M; Hassanian SM; Anvari K; Avan A
J Cell Physiol; 2018 Jan; 233(1):378-386. PubMed ID: 28266716
[TBL] [Abstract][Full Text] [Related]
19. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.
Scesnaite A; Jarmalaite S; Mutanen P; Anttila S; Nyberg F; Benhamou S; Boffetta P; Husgafvel-Pursiainen K
Mutagenesis; 2012 Jul; 27(4):423-9. PubMed ID: 22217548
[TBL] [Abstract][Full Text] [Related]
20. Association Between
Markulin D; Vojta A; Samaržija I; Gamulin M; Bečeheli I; Jukić I; Maglov Č; Zoldoš V; Fučić A
Cancer Genomics Proteomics; 2017; 14(5):363-372. PubMed ID: 28871003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]